LB Pharmaceuticals, Inc. (LBRX)
37.80
-1.39
(-3.55%)
USD |
NASDAQ |
Sep 24, 16:00
37.82
+0.02
(+0.05%)
After-Hours: 19:59
LB Pharmaceuticals Total Return Level : 37.80 for Sept. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 24, 2026 | 37.80 |
| September 23, 2026 | 39.19 |
| September 22, 2026 | 42.69 |
| September 21, 2026 | 42.99 |
| September 18, 2026 | 42.47 |
| September 17, 2026 | 42.14 |
| September 16, 2026 | 42.57 |
| September 15, 2026 | 43.04 |
| September 14, 2026 | 44.84 |
| September 11, 2026 | 44.63 |
| September 10, 2026 | 46.25 |
| September 09, 2026 | 47.67 |
| September 08, 2026 | 49.39 |
| September 04, 2026 | 49.34 |
| September 03, 2026 | 47.52 |
| September 02, 2026 | 49.48 |
| September 01, 2026 | 47.10 |
| August 31, 2026 | 47.26 |
| August 28, 2026 | 47.73 |
| August 27, 2026 | 47.89 |
| August 26, 2026 | 48.16 |
| August 25, 2026 | 48.80 |
| August 24, 2026 | 48.21 |
| August 21, 2026 | 47.62 |
| August 20, 2026 | 47.23 |
| Date | Value |
|---|---|
| August 19, 2026 | 48.94 |
| August 18, 2026 | 48.77 |
| August 17, 2026 | 46.23 |
| August 14, 2026 | 47.78 |
| August 13, 2026 | 44.27 |
| August 12, 2026 | 45.38 |
| August 11, 2026 | 45.33 |
| August 10, 2026 | 45.85 |
| August 07, 2026 | 48.00 |
| August 06, 2026 | 48.18 |
| August 05, 2026 | 45.03 |
| August 04, 2026 | 45.00 |
| August 03, 2026 | 42.84 |
| July 31, 2026 | 40.08 |
| July 30, 2026 | 40.90 |
| July 29, 2026 | 39.00 |
| July 28, 2026 | 34.94 |
| July 27, 2026 | 34.78 |
| July 24, 2026 | 35.01 |
| July 23, 2026 | 34.62 |
| July 22, 2026 | 35.84 |
| July 21, 2026 | 32.31 |
| July 20, 2026 | 30.90 |
| July 17, 2026 | 31.41 |
| July 16, 2026 | 30.59 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ligand Pharmaceuticals, Inc. | 397.93 |
| Neumora Therapeutics, Inc. | 0.7031 |
| ANI Pharmaceuticals, Inc. | 74.04 |
| Corcept Therapeutics, Inc. | 118.51 |
| Veru, Inc. | 2.934 |